comparison of glp 1 receptor agonists GLP-1 Agonist Market Size & Analysis, 2026-2033 Glucagon-like peptide-1 receptor agonists(GLP-1RAs)** GLP-1
Description
GLP-1s are medications designed to manage type 2 diabetes, heart disease and obesity by lowering blood sugar and A1C, interacting with the hunger part of the brain to suppress the appetite and slowing down the process of food emptying from the stomach, causing patients to feel full longer
The area under the tongue has a rich supply of blood vessels, which allows the medication to bypass the digestive system and liver
Most are injectable medications, although one oral formulation is currently available
Am J Clin Nutr 95: 7883
But animal studies dont always predict what will happen in people
